Shares of Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company developing therapies to treat blood coagulation disorders, made their Nasdaq Global Select Market debut under the ticker "COAG" on May 1, 2026.
The company priced its initial public offering (IPO) of 16.75 million shares at $18 per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.